Clinical Focus
Advertisement
Advertisement
Trending on Modern Retina
1
FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa
2
FDA expands faricimab label to include treatment of macular edema secondary to retinal vein occlusion beyond 6 months
3
Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease
4
Tattoo-associated uveitis: An emerging eye health challenge
5